Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb 13;7(5):ytad076.
doi: 10.1093/ehjcr/ytad076. eCollection 2023 May.

Use of transoesophageal echocardiography to detect and manage atrial thrombi in light-chain cardiac amyloidosis: a case report

Affiliations
Case Reports

Use of transoesophageal echocardiography to detect and manage atrial thrombi in light-chain cardiac amyloidosis: a case report

Toan Quang Dang et al. Eur Heart J Case Rep. .

Abstract

Background: Increased intracardiac thrombus formation in light-chain cardiac amyloidosis (AL-CA) has been associated with thrombotic events such as stroke and high rates of mortality and morbidity.

Case summary: A 51-year-old man was admitted to the emergency department with a sudden change in consciousness. His emergency brain magnetic resonance imaging showed two foci of cerebral infarction on the bilateral temporal lobes. His electrocardiogram displayed a normal sinus rhythm with low QRS voltage. Transthoracic echocardiography showed concentric thickened ventricles, dilatation of both atria, a left ventricular ejection fraction of 53%, and a Grade 3 diastolic dysfunction. The bull-eye plot on speckle tracking echocardiography displayed a distinctive apical sparing pattern. A serum-free immunoglobulin analysis showed increased lambda-free light chains (295.59 mg/L) with a reduced kappa/lambda ratio (0.08). Light-chain amyloidosis was subsequently confirmed by examining the histology of the abdominal fat-pad tissue. On transoesophageal echocardiography (TEE), an elongated static thrombus and a mobile bouncing oval thrombus were found on the left and right atrial appendages, respectively. Atrial thrombi were managed with a full dose of dabigatran of 150 mg twice daily, which resulted in a complete resolution after 2 months of TEE follow-up.

Discussion: Complicating intracardiac thrombosis has been considered one of the major contributions of death in cardiac amyloidosis. Transoesophageal echocardiography should be established to aid in the detection and management of atrial thrombus in AL-CA.

Keywords: Cardiac amyloidosis; Case report; Light chain; Thrombus; Transoesophageal echocardiography.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Brain magnetic resonance imaging showed two foci of cerebral infarctions in bilateral temporal lobes (A), cerebrovascular magnetic resonance imaging suggested the occlusion of the M3 branches (B), and 12-lead electrocardiogram indicated a sinus rhythm with some premature atrial beats and low QRS voltages on the limb leads (C).
Figure 2
Figure 2
Transthoracic echocardiography showed hypertrophic ventricles and enlarged atria on four-chamber view (A), an abnormally high E/A wave ratio of 3.11 on Doppler imaging (B), ‘apical sparing’ pattern (C), and reduced left atrial strain parameters (D) on speckle tracking echocardiography.
Figure 3
Figure 3
Abdominal fat-pad biopsy result was positive for Congo red staining (A), under polarized light (B), and for lambda light chain with immunofluorescence staining (C).
Figure 4
Figure 4
Thrombi (white arrows) with the presence of spontaneous contrast in the left (A1) and right (B1) atrial appendages on mid-oesophageal two-chamber view (80–90°) and mid-oesophageal bicaval view, respectively. Resolution of thrombi (asterisks) in the left (A2) and right (B2) atrial appendages after 2 months of anticoagulation therapy.

References

    1. Nicol M, Siguret V, Vergaro G, Aimo A, Emdin M, Dillinger JG, et al. . Thromboembolism and bleeding in systemic amyloidosis: a review. ESC Heart Fail 2022;9:11–20. - PMC - PubMed
    1. Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, et al. . Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 2007;116:2420–2426. - PubMed
    1. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. . Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021;42:1554–1568. - PMC - PubMed
    1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. . 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary. J Am Coll Cardiol 2022;79:1757–1780. - PubMed
    1. Martinez Naharro A, Kotecha T, Gonzalez-Lopez E, Corovic A, Anderson S, Chacko L, et al. . High prevalence of intracardiac thrombi in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 2019;73:1733–1734. - PubMed

Publication types

LinkOut - more resources